Obstetrics/Gynecology
RSSArticles
-
Clinicians Need More Research Data to Learn Best Practices in Contraceptive Counseling
New research shows more supportive counseling in reproductive health is needed for adolescents, especially after sexual initiation, and in support of adherence or tolerance of side effects. Access to different types of birth control has increased in the past decade, but not as much progress has been made in supporting decision-making or counseling with respect to neurodevelopmental functioning. -
Behavioral Change Techniques Are Needed to Reduce Unintended Pregnancies
Social and behavioral change are important factors to consider and incorporate into family planning, even before a woman enters a provider’s office. Some social and behavioral change tactics include shared decision-making, ideational models, multifaceted community campaigns, and value clarification exercises. -
Research Suggests the Need for More Sexual Health Education Among Providers
A new study revealed opportunities for improvement in OB/GYN knowledge of sexual health education. OB/GYN residents, while knowledgeable on subjects like decreased sexual desire, sexual pain, contraception, and more, could benefit from learning more about transgender care, caring for sex trafficking survivors, and cultural competency in care. -
Disease Severity and Perinatal Outcomes of Pregnant Patients with COVID-19
In this observational cohort study of patients with singleton gestation and positive coronavirus test, patients with severe or critical disease were at risk for perinatal complications compared to those who were asymptomatic. Patients classified with mild or moderate disease were not shown to have an increased risk compared to asymptomatic positive patients.
-
Standard-Dose vs. High-Dose Oxytocin for Labor Augmentation
In this randomized clinical trial of standard-dose vs. high-dose oxytocin regimens for labor augmentation among 1,003 nulliparous women, the primary outcome (cesarean delivery) was similar between the two groups. However, secondary outcomes were lower, labor duration was shorter, and umbilical artery acidemia occurred less frequently.
-
BSO at Benign Hysterectomy: What Should We Be Recommending?
In this population-based retrospective cohort study, among 44,549 adult women undergoing hysterectomy in Ontario, Canada, there was marked variation between surgeons in bilateral salpingo-oophorectomy (BSO) rates after controlling for patient age and other factors. Approximately 41% of patients had no indication for the bilateral salpingo-oophorectomy in their records.
-
Mifepristone as an Adjunct to Misoprostol for Pregnancy Termination
In this prospective, double-blind, randomized, placebo-controlled trial, pretreatment with 200 mg of mifepristone 24 to 48 hours before labor induction using misoprostol significantly reduced time to delivery among demised fetuses between 14 and 28 weeks of gestation. Maternal complications were equivalent in both groups.
-
Changes to Medication Abortion Could Result in Pharmacy Dispensing of the Drug
The easing of the risk evaluation and mitigation strategy restriction on mifepristone will make it easier for women to obtain the drug and could allow for pharmacy dispensing of the drug. Pharmacists should have a seat at the table in the conversation on dispensing prescription medication. -
Researchers Say It Is Time to Drop REMS Restriction on Mifepristone
The risk evaluation and mitigation strategy (REMS) restriction on mifepristone has been burdensome for providers and patients, researchers noted. The REMS restriction exacerbates the stigma around abortion care, which already disproportionately affects communities of color and young people. -
Disease-Specific Contraceptive Counseling Needed for Sickle Cell Disease Patients
Healthcare providers need to focus on educating women with sickle cell disease about different types of contraception, efficacy, and risks while addressing disease-specific concerns. Women with sickle cell disease are at risk for pregnancy complications, such as higher risks for maternal and fetal mortality, pre-eclampsia, and intrauterine growth restriction.